GPX1 and pancreatic neoplasm: Meng et al. demonstrated that in a pancreatic cancer cell line, silencing of Gpx-1 promotes a mesenchymal phenotype and gemcitabine resistance through activation of the ROS-mediated Akt/GSK3β/Snail signalling axis [27].